Cannabis News
Authoritative coverage of the global cannabis industry — regulation, investment, markets and policy, reported for the people who run it.
Cannabis News · page 50
- Adult-Use
California Cannabis Sellers Race to Block 27% Tax Hike as Industry Reaches Breaking Point
California’s embattled legal cannabis industry is facing a significant spike in taxation in the coming weeks, but efforts are underway to block the potentially ruinous bill before it is enforced.
- Uncategorized
MJ Berlin x Business of Cannabis Unveils Programme for 2025 International Cannabis Business Day
Prohibition Partners and Mary Jane Berlin are pleased to announce the full speaker line-up and agenda for the inaugural International Cannabis Business Day, taking place on Thursday, June 19, 2025, at Messe Berlin.
- Uncategorized
Denmark Legalises Medical Cannabis Permanently, but ‘Ludicrous’ Subsidy Gap Remains
Denmark has officially passed legislation which will solidify its long-running medical cannabis pilot programme as a permanent fixture of its national healthcare system in what has been described as a ‘victory for patients’.
- Uncategorized
Public Health, Pilot Projects and Politics: Mapping Adult-Use Cannabis in Europe
We have delved into some of the key data and insights set to be integrated into the new site, providing a taste of what readers can expect. For further exclusive analysis into the European cannabis market, pre-orders for data packages are available now.
- Uncategorized
The Business of Cannabis Awards 2025: Call for Entries Now Open
We are pleased to announce that entries are now open for the Business of Cannabis Awards 2025 — the leading event recognising excellence across Europe’s cannabis sector.
- Uncategorized
Full-Spectrum CBD Drug for Autism Spectrum Disorder Poised for Phase 2 Clinical Trials in the US
DeFloria, a joint venture between Charlotte’s Web Holdings and Ajna BioSciences, is advancing toward the start of its Phase 2 clinical trial for AJA001, a cannabinoid-based (FDA) botanical drug developed to treat behavioral symptoms associated with autism spectrum disorder (ASD).
- Hemp Industry
High Court Steps in to Arizona ‘Consumable Hemp’ Battle, Offering Hope to Industry
Arizona’s hemp industry this week received a welcome reprieve from an overnight ban on all ‘consumable hemp products’, as the Court of Appeals agreed to consider a collaborative pushback from the industry.
- CBD Market
Hemp Farmers Switch To Corn As Italian CBD Industry Fights Extinction
Former hemp farmers are switching to corn, and larger players are leaving Italy altogether as its once-thriving hemp and CBD industry is battered by the hard-line government.
- Uncategorized
How Cannabis Businesses are Using Employee Stock Ownership Plans to Avoid 280e Tax
When Maryland Gov. Wes Moore signed a law on April 22 exempting employee stock ownership plans (ESOPs) from the state’s strict five-year license-hold requirement for cannabis businesses, he opened up an exit strategy for founders.
- Uncategorized
Cannabis Rescheduling Given Fresh Hope as DEA Nominee Pledges to ‘Look at Science and Listen to Experts’
Cannabis rescheduling was thrown back into the spotlight last week as the new potential head of the Drug Enforcement Administration (DEA) said it would be a ‘priority’.
- CBD Market
French CBD Industry Under Attack From Food Regulators
THE latest move by the French authorities to undermine the country’s thriving CBD industry will be met with widespread resistance, say the industry’s leading trade bodies.
- Data & Analysis
The ‘Glaring Omission’ of the Endocannabinoid System From Mainstream Medical Knowledge, And its Real World Impact
Despite being one of the most important regulatory systems in human physiology, the endocannabinoid system (ECS) remains inexplicably absent from almost all mainstream medical education.
